AVAX Price Prediction: Wedge pattern breakout sets the AVAX price for a prolonged recovery; time to enter? Published 5 seconds ago AVAX Price Prediction: Under
Category: Avalanche (AVAX)
Friend Tech Rival Stars Arena Confirms Protocol Exploit
Stars Arena, the Avalanche-based rival of social protocol Friend Tech, has recently confirmed a protocol exploit that resulted in a staggering loss of 266,103 AVAX
AVAX dips below $13 – Sellers seeking re-entry can target this level
Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion The $13 support area
Avalanche eases to a bullish zone, but…
Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion. Price action eased to
Why AVAX is unable to cross $14
Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion. AVAX faltered at its
Avalanche bulls hesitate near $14 because…
Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion. AVAX was yet to
AVAX crosses the $12 obstacle – Where to next?
Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion. $12 has been a
Avalanche [AVAX] reclaims range low – Is the rally sustainable
Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion AVAX inflicted a bearish
Avalanche [AVAX] consolidates near supply zone; Is a pullback likely?
Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion AVAX was bullish, but
AVAX reclaims Q1 2023 highs, hits key supply level- A cool-off likely?
Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion –